All Regulatory Rapporteur articles in January 2026
View all stories from this issue.
-
EditorialNavigating complexity: Regulation at the interface of innovation, technology and confidence
This issue focuses on complex products, with articles on brain-computer interfaces, radiopharmaceuticals and sophisticated generic products, and explores how regulatory systems can remain robust and predictable while enabling novel technologies to reach patients.
-
ContentsRegulatory Rapporteur January 2026 – Contents
The January issue of Regulatory Rapporteur focuses on complex products.
-
JournalOverview of the regulatory and development landscape for brain-computer interfaces in neurodegenerative disease treatment
This article explores brain-computer interfaces (BCIs) for neurodegenerative disease treatments.
-
JournalRegulatory challenges and key considerations in the development of radiopharmaceuticals
This article looks at CMC, clinical and non-clinical considerations in the development of radiopharmaceuticals.
-
JournalEmpowering digital innovation in CMC: A framework for regulatory readiness and confidence
This article looks at the evolution of CMC and technologies, such as AI, to help with applications, regulatory assessments and more.
-
JournalThe evolving role of the regulatory professional in the age of Artificial Intelligence
This article explores how artificial intelligence can be used across dossier preparation, CMC, clinical development and more.
-
Journal2025 UK MDR Regulatory Conference: Meeting report
This article is a report of the 2025 UK MDR Regulatory Conference that was hosted by TOPRA and RAPS.
-
JournalDemystifying complex generic products: Regulatory pathways and characterisation
This article explores complex generic products, providing guidance for their definition and classification.
-
PodcastsRegRapPod − InConversation with Parexel
InConversation talks Joint Clinical Assessment with Sangeeta Budhia and Sinan Sarac